Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
96.45 EUR
-1.98%
Updated:
May 21, 2024
P/S
Price to Sales
Price to Sales
1.7
Current
1.6
Median
3.8
Industry
Higher
than median
Lower
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=1.7
Market Cap
/
3.3B
Revenue
2B
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| DE |
|
Gerresheimer AG
XETRA:GXI
|
3.3B EUR | 1.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
226.7B USD | 5.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
197.8B USD | 4.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
45.3B USD | 6.7 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.5B CHF | 5.6 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.8B USD | 2.8 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 15 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.4B USD | 8.6 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.4B USD | 3.2 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
25B USD | 8.5 | |
| US |
|
Waters Corp
NYSE:WAT
|
21B USD | 7.2 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
1.5
2-Years Forward
P/S
1.4
3-Years Forward
P/S
1.3
You don't have any saved screeners yet
